Carnobacteriocin B2

General Information


DRACP ID  DRACP03523

Peptide Name   Carnobacteriocin B2

Sequence  VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP

Sequence Length  48

UniProt ID  P38580 

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  1CW5 

Predicted Structure  DRACP03523

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C213H332N66O68S2

Absent amino acids  DHLM

Common amino acids  G

Mass  580799

Pl  9.96

Basic residues  5

Acidic residues  1

Hydrophobic residues  14

Net charge  4

Boman Index  -7388

Hydrophobicity  -27.71

Aliphatic Index  54.79

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  8605

Absorbance 280nm  183.09

Polar residues  25

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19271288

Title  Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6227

DRACP is developed by Dr.Zheng's team.